In The News

IP Litigators Analyze Section 112 Biopharma Post-Grant Review Patent Challenges

Practices: Intellectual Property, Intellectual Property Litigation, Patent Strategy, Patent Trial & Appeal Board (PTAB) Proceedings, Life Sciences, Technology, Media & Telecommunications, Litigation

Capital Insights.

In the Kluwer Patent Blog, IP litigation associate Meredith Foor analyzed trends in Section 112 challenges in Post-Grant Reviews at the Patent Trial and Appeal Board, an important issue for biotechnology, pharmaceutical and chemical patent invalidity claims.

Cookie Settings